← All Sponsors
SPONSOR

Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 3
Conditions studied: Solid TumorsPsoriasis
NCT06963281 Phase 1
Recruiting

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Solid Tumors
United States, China View Trial →
NCT07265284 Phase 3
Recruiting

A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Psoriasis
China View Trial →